Polymyxin B and Trimethoprim Sulfates Ophthalmic Solution Shortage
Last Updated: March 24, 2024
Status: Current
Products Affected - Description
-
- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Akorn, 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 17478-0703-11 - discontinued
- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Greenstone (Viatris), 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 60758-0908-10 - discontinued
- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Sandoz, 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 61314-0628-10
Reason for the Shortage
-
- Akorn ceased operations in February 2023.
- Bausch Health polymixin B and trimethoprim sulfates ophthalmic solution available.
- Greenstone (Viatris) discontinued polymyxin B and trimethoprim sulfates ophthalmic solution in 2022.
- Sandoz did not provide a reason for the shortage.
Available Products
-
- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Bausch Health, 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 24208-0315-10
Estimated Resupply Dates
-
- Sandoz has polymixin B and trimethoprim sulfates ophthalmic solution on back order and the company estimates a release date of late-March 2024.
Updated
Updated March 24, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created March 31, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.